(Q44418948)

2 December 2017

title

A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression (English)

1 reference

2 December 2017

Lin Xu

12

0 references

author name string

Chen Zhang

1

1 reference

2 December 2017

Zezhi Li

2

1 reference

2 December 2017

Zhiguo Wu

3

1 reference

2 December 2017

Jun Chen

4

1 reference

2 December 2017

Zuowei Wang

5

1 reference

2 December 2017

Daihui Peng

6

1 reference

2 December 2017

Wu Hong

7

1 reference

2 December 2017

Chengmei Yuan

8

1 reference

2 December 2017

Zhen Wang

9

1 reference

2 December 2017

Shunying Yu

10

1 reference

2 December 2017

Yifeng Xu

11

1 reference

2 December 2017

Zeping Xiao

13

1 reference

2 December 2017

Yiru Fang

14

1 reference

2 December 2017

publication date

11 October 2013

1 reference

2 December 2017

1 reference

2 December 2017

volume

231

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

685-693

1 reference

Ketamine for depression: where do we go from here?

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Plasma and platelet excitatory amino acids in psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

TMPRSS9 and GRIN2B are associated with neuroticism: a genome-wide association study in a European sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

The neurobiology of the EEG biomarker as a predictor of treatment response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Augmentation strategies for treatment-resistant depression: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Synaptic dysfunction in depression: potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Is treatment-resistant depression a unique subtype of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Corticotropin-releasing hormone, glutamate, and γ-aminobutyric acid in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Interaction of 5-HTTLPR genotype and unipolar major depression in the emergence of aggressive/hostile traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Increased levels of glutamate in brains from patients with mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Molecular genetics of bipolar disorder and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Association study of polymorphisms in N-methyl-D-aspartate receptor 2B subunits (GRIN2B) gene with Korean alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

The pharmacogenetics of major depression: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Pharmacogenetic response to antidepressants in a multicase family with affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Research issues in the study of difficult-to-treat depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Genetic epidemiology of major depression: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

A neuropeptide Y variant (rs16139) associated with major depressive disorder in replicate samples from Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Treatment-resistant depression: critique of current approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Association of genetic variation in CACNA1C with bipolar disorder in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Positive association between GRIN2B gene and bipolar disorder in the Chinese Han Population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3297-0

Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods

21 January 2018

1 reference

12 December 2020

[Mapping genes related to early onset major depressive disorder in Dagestan genetic isolates]

1 reference

12 December 2020

Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

1 reference

12 December 2020

A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.

1 reference

12 December 2020

Cost burden of treatment resistance in patients with depression.

1 reference

12 December 2020

Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms

1 reference

12 December 2020

Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies

1 reference

12 December 2020

Global burden of depression: the intersection of culture and medicine

1 reference

12 December 2020

10.1007/S00213-013-3297-0

Identifiers

DOI

1 reference

2 December 2017

1 reference